Trials / Conditions / Infarction, Middle Cerebral Artery

Infarction, Middle Cerebral Artery

15 registered clinical trials studyying Infarction, Middle Cerebral Artery — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 NCT05899582	Xuanwu Hospital, Beijing	N/A
Completed	Testing of Identification Markers for Stroke NCT04292600	POCKiT diagnostics Ltd	—
Completed	An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam NCT03679364	KPC Pharmaceuticals, Inc	—
Unknown	Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients NCT04093336	Shanghai East Hospital	Phase 1 / Phase 2
Suspended	Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial NCT03098732	Pulse Therapeutics	N/A
Terminated	Thrombectomy Under Reopro Versus Alteplase to Treat Stoke NCT02016547	SOS Attaque Cérébrale	Phase 4
Unknown	Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke NCT01438593	China Medical University Hospital	Phase 1
Completed	A Comparison Between Two Techniques for Performing Decompressive Craniectomy NCT02594137	Hospital of the Restoration, Recife	N/A
Completed	Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke NCT01468064	Southern Medical University, China	Phase 1 / Phase 2
Unknown	Implantation of Olfactory Ensheathing Cells (OECs) NCT01327768	China Medical University Hospital	Phase 1
Completed	Impact of Cranioplasty On Cerebral Perfusion NCT01113645	Assistance Publique - Hôpitaux de Paris	—
Completed	Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. NCT00761982	Hospital Universitario Central de Asturias	Phase 1 / Phase 2
Completed	Autologous Bone Marrow Stem Cells in Ischemic Stroke. NCT00535197	Imperial College London	Phase 1 / Phase 2
Completed	Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke NCT00473057	Universidade Federal do Rio de Janeiro	Phase 1
Completed	Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke NCT00604630	Max-Planck-Institute of Experimental Medicine	Phase 2 / Phase 3